PhotoCure ASAFRA:PHS -0.76%73 Days Inventory is 358.36 as of Mar. 2026, which is 19% below its 10-year median of 439.86. GuruFocus rates FRA:PHS with a GF Score™ of 73/100 and a GF Value™ of €6.33 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, PhotoCure ASA ranks worse than 87.16% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). PhotoCure ASA's Average Total Inventories for the
three
months ended in Mar. 2026 was €3.64 Mil. PhotoCure ASA's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.93 Mil.
Hence, PhotoCure ASA's Days Inventory for the
three
months ended in Mar. 2026 was 358.36.
The historical rank and industry rank for PhotoCure ASA's Days Inventory or its related term are showing as below:
FRA:PHS'
s Days Inventory Range Over the Past 10 Years
Min: 283.68 Med: 439.86 Max: 611.16
Current: 328.04
During the past 13 years, PhotoCure ASA's highest Days Inventory was 611.16. The lowest was 283.68. And the median was 439.86.
FRA:PHS's Days Inventory is ranked worse than 87.16% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs FRA:PHS: 328.04
PhotoCure ASA's Days Inventory
declined
from Mar. 2025 (384.53) to Mar. 2026 (358.36).
Inventory Turnover measures how fast the company turns over its inventory within a year.
PhotoCure ASA's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.25.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PhotoCure ASA's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.15.
PhotoCure ASA (FRA:PHS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
PhotoCure ASA's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
PhotoCure ASA's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
PhotoCure ASA Days Inventory Related Terms
PhotoCure ASA Days Inventory Historical Data
* Premium members only.
The historical data trend for PhotoCure ASA's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PHS vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PhotoCure ASA's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PhotoCure ASA Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PhotoCure ASA's Days Inventory distribution charts can be found below:
* The bar in red indicates where PhotoCure ASA's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PhotoCure ASA (FRA:PHS) has a Days Inventory of 358.36 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PhotoCure ASA and its competitors. This is 19% below median its historical median of 439.86. Over the past decade, PhotoCure ASA's Days Inventory has ranged from 283.68 to 611.16. According to the industry distribution chart, PhotoCure ASA ranks #801 out of 919 companies in the Drug Manufacturers industry, placing it in the top 87.2%.
Is PhotoCure ASA's Days Inventory too high?
PhotoCure ASA's current Days Inventory of 358.36 is 19% below median its 10-year median of 439.86. Over the past 10 years, this metric has ranged from a low of 283.68 to a high of 611.16. The Drug Manufacturers industry median Days Inventory is 162.83. PhotoCure ASA's value of 358.36 is 120.1% above this industry median. Based on the distribution chart, PhotoCure ASA ranks #801 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PhotoCure ASA has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PhotoCure ASA's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PhotoCure ASA ranks #801 out of 919 companies for Days Inventory. This places PhotoCure ASA in the lower half of its industry. The industry median Days Inventory is 162.83. PhotoCure ASA's value of 358.36 is 120.1% above this benchmark. Historically, PhotoCure ASA's own Days Inventory has ranged from 283.68 to 611.16 over the past decade. While the company's 10-year median is 439.86 vs. the industry median of 162.83, PhotoCure ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PhotoCure ASA's current Days Inventory of 358.36 is 120.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on PhotoCure ASA and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhotoCure ASA's current Days Inventory is 358.36, which is 19% below median its own 10-year median of 439.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhotoCure ASA stock overvalued right now?
Based on GuruFocus' analysis, PhotoCure ASA (FRA:PHS) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.33, compared to a current price of €5.19 — trading 18% below its estimated fair value. The current Days Inventory is 358.36, which is 19% below median its 10-year median of 439.86 and 120.1% above the Drug Manufacturers industry median of 162.83. PhotoCure ASA's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For PhotoCure ASA (FRA:PHS), the current Days Inventory is 358.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PhotoCure ASA (FRA:PHS) Overvalued in 2026?
Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued.
The current stock price of €5.19 is trading 18% below its estimated GF Value™ of €6.33.
GuruFocus considers PhotoCure ASA to be Modestly Undervalued.
Key valuation signals for FRA:PHS:
Days Inventory: 358.36 (19% below median its 10-year median of 439.86)
GF Value™: €6.33 vs. price of €5.19 (18% below fair value)
Industry Position: 120.1% above the Drug Manufacturers median (#801 of 919)
No single metric tells the full story. See the FRA:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.
73GF Score
Get the complete analysis for FRA:PHS
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHS has been successfully added to your 
